다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
AI-Helper
Autism spectrum disorder (ASD) is a severe neuropsychiatric disease with strong genetic underpinnings. However, genetic contributions to autism are extremely heterogeneous, with many different loci underlying the disease to a different extent in different individuals. Moreover, the phenotypic expres...
Nervous Child Kanner 2 217 1943 Autistic disturbances of affective contact
American Psychiatric Association 1994 Diagnostic and statistical manual of mental disorders
Journal of Child Psychology and Psychiatry Bailey 37 89 1996 10.1111/j.1469-7610.1996.tb01381.x Autism: towards an integration of clinical, genetic, neuropsychological, and neurobiological perspectives
Journal of the American Academy of Child and Adolescent Psychiatry McPartland 51 368 2012 10.1016/j.jaac.2012.01.007 Sensitivity and specificity of proposed DSM-5 diagnostic criteria for autism spectrum disorder
American Journal of Psychiatry Piven 154 185 1997 10.1176/ajp.154.2.185 Broader autism phenotype: evidence from a family history study of multiple-incidence autism families
Archives of General Psychiatry Constantino 60 524 2003 10.1001/archpsyc.60.5.524 Autistic traits in the general population: a twin study
American Journal of Psychiatry Gottesman 160 636 2003 10.1176/appi.ajp.160.4.636 The endophenotype concept in psychiatry: etymology and strategic intentions
Persico 2013 The comprehensive guide to autism Endophenotypes in Autism Spectrum Disorders
Trends in Cognitive Sciences Geschwind 15 409 2011 10.1016/j.tics.2011.07.003 Genetics of autism spectrum disorders
Archives of General Psychiatry Hallmayer 68 1095 2011 10.1001/archgenpsychiatry.2011.76 Genetic heritability and shared environmental factors among twin pairs with autism
Pediatrics Ozonoff 128 e488 2011 10.1542/peds.2010-2825 Recurrence risk for autism spectrum disorders: a baby siblings research consortium study
Journal of Medical Genetics Lintas 46 1 2009 10.1136/jmg.2008.060871 Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist
Current Opinion in Genetics & Development Devlin 22 229 2012 10.1016/j.gde.2012.03.002 Genetic architecture in autism spectrum disorder
Pediatric Clinics of North America Toriello 59 113 2012 10.1016/j.pcl.2011.10.014 Approach to the genetic evaluation of the child with autism
Dialogues in Clinical Neuroscience Buxbaum 11 35 2009 10.31887/DCNS.2009.11.1/jdbuxbaum Multiple rare variants in the etiology of autism spectrum disorders
Annual Review of Medicine Krueger 62 411 2011 10.1146/annurev-med-061109-134644 Toward fulfilling the promise of molecular medicine in fragile X syndrome
Journal of Child Neurology Curatolo 25 873 2010 10.1177/0883073810361789 Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment
Nature Santini 493 411 2013 10.1038/nature11782 Exaggerated translation causes synaptic and behavioural aberrations associated with autism
Cell Kelleher 135 401 2008 10.1016/j.cell.2008.10.017 The autistic neuron: troubled translation?
Nature Reviews Neuroscience Bagni 6 376 2005 10.1038/nrn1667 From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome
American Journal of Human Genetics Rousseau 57 1006 1995 Prevalence of carriers of premutation-size alleles of the FMR1 gene and implications for the population genetics of the fragile X syndrome
Molecular Autism Hagerman 1 12 2010 10.1186/2040-2392-1-12 Fragile X and autism: intertwined at the molecular level leading to targeted treatments
American Journal of Medical Genetics Kaufmann 129A 225 2004 10.1002/ajmg.a.30229 Autism spectrum disorder in fragile X syndrome: communication, social interaction, and specific behaviors
American Journal on Intellectual and Developmental Disabilities McDuffie 115 307 2010 10.1352/1944-7558-115.4.307 Autism spectrum disorder in children and adolescents with fragile X syndrome: within-syndrome differences and age-related changes
Front Psychology Losh 3 266 2012 10.3389/fpsyg.2012.00266 Social communication and theory of mind in boys with autism and fragile x syndrome
Current Genomics Napolioni 9 475 2008 10.2174/138920208786241243 Genetics and molecular biology of tuberous sclerosis complex
Journal of Autism and Developmental Disorders Gutierrez 28 97 1998 10.1023/A:1026032413811 Autism in tuberous sclerosis complex
New England Journal of Medicine Crino 355 1345 2006 10.1056/NEJMra055323 The tuberous sclerosis complex
American Journal of Medical Genetics Part A Hatton 140A 1804 2006 10.1002/ajmg.a.31286 Autistic behavior in children with fragile X syndrome: prevalence, stability, and the impact of FMRP
Brain and Cognition Meguid 78 74 2012 Cognition and lobar morphology in full mutation boys with fragile X syndrome
Molecular Autism Chaste 3 5 2012 10.1186/2040-2392-3-5 High-functioning autism spectrum disorder and fragile X syndrome: report of two affected sisters
Developmental Medicine and Child Neurology van Eeghen 55 146 2013 10.1111/dmcn.12044 Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach
Molecular Autism Bahl 4 5 2013 10.1186/2040-2392-4-5 Lack of association of rare functional variants in TSC1/TSC2 genes with autism spectrum disorder
Neuropharmacology Yan 49 1053 2005 10.1016/j.neuropharm.2005.06.004 Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP
Journal of Child and Adolescent Psychopharmacology Berry-Kravis 16 525 2006 10.1089/cap.2006.16.525 Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial
Science Translational Medicine Henderson 4 152ra128 2012 10.1126/scitranslmed.3004218 Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABA(B) receptors with arbaclofen
Nature Medicine Ehninger 14 843 2008 10.1038/nm1788 Reversal of learning deficits in a Tsc21/2 mouse model of tuberous sclerosis
Journal of Neuroscience Meikle 28 5422 2008 10.1523/JNEUROSCI.0955-08.2008 Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function
Nature Auerbach 480 63 2011 10.1038/nature10658 Mutations causing syndromic autism define an axis of synaptic pathophysiology
Journal of Neuroscience Zhong 32 12841 2012 10.1523/JNEUROSCI.2784-12.2012 MeCP2 phosphorylation is required for modulating synaptic scaling through mGluR5
Science Baudouin 338 128 2012 10.1126/science.1224159 Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism
Trends in Pharmacological Sciences Spooren 33 669 2012 10.1016/j.tips.2012.09.004 Synapse dysfunction in autism: a molecular medicine approach to drug discovery in neurodevelopmental disorders
Nature Redon 444 444 2006 10.1038/nature05329 Global variation in copy number in the human genome
Journal of Medical Genetics Jacquemont 43 843 2006 10.1136/jmg.2006.043166 Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders
Science Sebat 316 445 2007 10.1126/science.1138659 Strong association of de novo copy number mutations with autism
American Journal of Human Genetics Marshall 82 477 2008 10.1016/j.ajhg.2007.12.009 Structural variation of chromosomes in autism spectrum disorder
Biological Psychiatry Christian 63 1111 2008 10.1016/j.biopsych.2008.01.009 Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder
PLoS Genetics Bucan 5 e1000536 2009 10.1371/journal.pgen.1000536 Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes
Nature Glessner 459 569 2009 10.1038/nature07953 Autism genome-wide copy number variation reveals ubiquitin and neuronal genes
Nature Pinto 466 368 2010 10.1038/nature09146 Functional impact of global rare copy number variation in autism spectrum disorders
Neuron Sanders 70 863 2011 10.1016/j.neuron.2011.05.002 Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism
Neuron Levy 70 886 2011 10.1016/j.neuron.2011.05.015 Rare de novo and transmitted copy-number variation in autistic spectrum disorders
Neuron Gilman 70 898 2011 10.1016/j.neuron.2011.05.021 Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses
Journal of Medical Genetics Rajcan-Separovic 44 269 2007 10.1136/jmg.2006.045013 Clinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1
New England Journal of Medicine Weiss 358 667 2008 10.1056/NEJMoa075974 Association between microdeletion and microduplication at 16p11.2 and autism
Human Molecular Genetics Kumar 17 628 2008 10.1093/hmg/ddm376 Recurrent 16p11.2 microdeletions in autism
Journal of Medical Genetics Liang 46 645 2009 10.1136/jmg.2008.059220 A newly recognised microdeletion syndrome of 2p15-16.1 manifesting moderate developmental delay, autistic behaviour, short stature, microcephaly, and dysmorphic features: a new patient with 3.2Mb deletion
Journal of Medical Genetics Fernandez 47 195 2010 10.1136/jmg.2009.069369 Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder
Trends in Neurosciences Betancur 32 402 2009 10.1016/j.tins.2009.04.003 The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders
Nature Südhof 455 903 2008 10.1038/nature07456 Neuroligins and neurexins link synaptic function to cognitive disease
Current Opinion in Neurobiology Craig 17 43 2007 10.1016/j.conb.2007.01.011 Neurexin-neuroligin signaling in synapse development
Neuron Fabrichny 56 979 2007 10.1016/j.neuron.2007.11.013 Structural analysis of the synaptic protein neuroligin and its β-neurexin complex: determinants for folding and cell adhesion
Cell Scheiffele 101 657 2000 10.1016/S0092-8674(00)80877-6 Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons
Neuron Gerrow 49 547 2006 10.1016/j.neuron.2006.01.015 A preformed complex of postsynaptic proteins is involved in excitatory synapse development
Nature Genetics Jamain 34 27 2003 10.1038/ng1136 Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
Science Tabuchi 318 71 2007 10.1126/science.1146221 A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice
Autism Research Chadman 1 147 2008 10.1002/aur.22 Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice
Journal of Neuroscience Comoletti 24 4889 2004 10.1523/JNEUROSCI.0468-04.2004 The Arg451Cys-neuroligin-3 mutation associated with autism reveals a defect in protein processing
Human Molecular Genetics Chih 13 1471 2004 10.1093/hmg/ddh158 Disorder-associated mutations lead to functional inactivation of neuroligins
Journal of Biological Chemistry Chubykin 280 22365 2005 10.1074/jbc.M410723200 Dissection of synapse induction by neuroligins: effect of a neuroligin mutation associated with autism
Proceedings of the National Academy of Sciences of the United States of America Etherton 108 13764 2011 10.1073/pnas.1111093108 Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function
Molecular Psychiatry Yan 10 329 2005 10.1038/sj.mp.4001629 Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients
EMBO Journal Etherton 30 2908 2011 10.1038/emboj.2011.182 An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus
Molecular Psychiatry Durand 17 71 2012 10.1038/mp.2011.57 SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism
Molecular Syndromology Phelan 2 186 2011 10.1159/000334260 The 22q13.3 deletion syndrome (Phelan-McDermid Syndrome)
BMC Medical Genetics Qin 10 61 2009 10.1186/1471-2350-10-61 Association study of SHANK3 gene polymorphisms with autism in Chinese Han population
European Journal of Human Genetics Sykes 17 1347 2009 10.1038/ejhg.2009.47 Copy number variation and association analysis of SHANK3 as a candidate gene for autism in the IMGSAC collection
Proceedings of the National Academy of Sciences of the United States of America Gauthier 107 7863 2010 10.1073/pnas.0906232107 De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia
Nature Genetics Durand 39 25 2007 10.1038/ng1933 Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders
American Journal of Human Genetics Moessner 81 1289 2007 10.1086/522590 Contribution of SHANK3 mutations to autism spectrum disorder
European Journal of Human Genetics Boccuto 21 310 2013 10.1038/ejhg.2012.175 Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders
Nature Genetics Berkel 42 489 2010 10.1038/ng.589 Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation
PLoS Genetics Leblond 8 e1002521 2012 10.1371/journal.pgen.1002521 Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders
American Journal of Human Genetics Sato 90 879 2012 10.1016/j.ajhg.2012.03.017 SHANK1 deletions in males with autism spectrum disorder
Cell Ichtchenko 81 435 1995 10.1016/0092-8674(95)90396-8 Neuroligin 1: a splice site-specific ligand for beta-neurexins
Nature Missler 423 939 2003 10.1038/nature01755 Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis
Journal of Neuroscience Zhang 25 4330 2005 10.1523/JNEUROSCI.0497-05.2005 Extracellular domains of alpha-neurexins participate in regulating synaptic transmission by selectively affecting N- and P/Q-type Ca2+ channels
Journal of Medical Genetics Zahir 45 239 2008 10.1136/jmg.2007.054437 A patient with vertebral, cognitive and behavioural abnormalities and a de novo deletion of NRXN1alpha
Human Molecular Genetics Need 18 4650 2009 10.1093/hmg/ddp413 A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB
PLoS Genetics Need 5 e1000373 2009 10.1371/journal.pgen.1000373 A genome-wide investigation of SNPs and CNVs in schizophrenia
American Journal of Human Genetics Vrijenhoek 83 504 2008 10.1016/j.ajhg.2008.09.011 Recurrent CNVs disrupt three candidate genes in schizophrenia patients
Schizophrenia Bulletin Kirov 35 851 2009 10.1093/schbul/sbp079 Neurexin 1 (NRXN1) deletions in schizophrenia
Human Molecular Genetics Rujescu 18 988 2009 10.1093/hmg/ddn351 Disruption of the neurexin 1 gene is associated with schizophrenia
Human Genetics Gauthier 130 563 2011 10.1007/s00439-011-0975-z Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Ching 153B 937 2010 10.1002/ajmg.b.31063 Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders
Proceedings of the National Academy of Sciences of the United States of America Etherton 106 17998 2009 10.1073/pnas.0910297106 Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments
PLoS ONE Laarakker 7 e31503 2012 10.1371/journal.pone.0031503 Sex-dependent novelty response in neurexin-1α mutant mice
American Journal of Human Genetics Vaags 90 133 2012 10.1016/j.ajhg.2011.11.025 Rare deletions at the neurexin 3 locus in autism spectrum disorder
Nature Genetics Amir 23 185 1999 10.1038/13810 Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Neuron Chahrour 56 422 2007 10.1016/j.neuron.2007.10.001 The story of Rett syndrome: from clinic to neurobiology
Journal of Medical Genetics Lam 37 e41 2000 10.1136/jmg.37.12.e41 Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Gong 147B 830 2008 10.1002/ajmg.b.30688 Analysis of X chromosome inactivation in autism spectrum disorders
European Journal of Pediatrics Young 167 661 2008 10.1007/s00431-007-0569-x The diagnosis of autism in a female: could it be Rett syndrome?
Early Human Development Tripi 84 217 2008 10.1016/j.earlhumdev.2007.04.005 Minor physical anomalies in children with autism spectrum disorder
Biological Psychiatry Sacco 62 1038 2007 10.1016/j.biopsych.2007.04.039 Clinical, morphological, and biochemical correlates of head circumference in autism
Archives of General Psychiatry Chawarska 68 1021 2011 10.1001/archgenpsychiatry.2011.106 Early generalized overgrowth in boys with autism
Neuron Courchesne 56 399 2007 10.1016/j.neuron.2007.10.016 Mapping early brain development in autism
Nature Chisaka 355 516 1992 10.1038/355516a0 Developmental defects of the ear, cranial nerves, and hindbrain resulting from targeted disruption of the mouse homeobox gene Hox-1.6
Developmental Biology Makki 357 295 2011 10.1016/j.ydbio.2011.06.042 Identification of novel Hoxa1 downstream targets regulating hindbrain, neural crest and inner ear development
Teratology Ingram 62 393 2000 10.1002/1096-9926(200012)62:6<393::AID-TERA6>3.0.CO;2-V Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders
Biological Psychiatry Conciatori 55 413 2004 10.1016/j.biopsych.2003.10.005 Association between the HOXA1 A218G polymorphism and increased head circumference in patients with autism
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Muscarella 144B 388 2007 10.1002/ajmg.b.30469 HOXA1 gene variants influence head growth rates in humans
Journal of Neuroimaging Canu 19 353 2009 10.1111/j.1552-6569.2008.00326.x HOXA1 A218G polymorphism is associated with smaller cerebellar volume in healthy humans
Molecular Autism Muscarella 1 9 2010 10.1186/2040-2392-1-9 Candidate gene study of HOXB1 in autism spectrum disorder
Autism Research Raznahan 5 93 2012 10.1002/aur.238 Allelic variation within the putative autism spectrum disorder risk gene homeobox A1 and cerebellar maturation in typically developing children and adolescents
PLoS ONE Song 6 e25603 2011 10.1371/journal.pone.0025603 An integrated meta-analysis of two variants in HOXA1/HOXB1 and their effect on the risk of autism spectrum disorders
Nature Genetics Tischfield 37 1035 2005 10.1038/ng1636 Homozygous HOXA1 mutations disrupt human brainstem, inner ear, cardiovascular and cognitive development
Neurology Bosley 69 1245 2007 10.1212/01.wnl.0000276947.59704.cf Clinical characterization of the HOXA1 syndrome BSAS variant
American Journal of Medical Genetics Part A Bosley 146A 1235 2008 10.1002/ajmg.a.32262 The clinical spectrum of homozygous HOXA1 mutations
European Journal of Human Genetics Blumenthal 16 1289 2008 10.1038/ejhg.2008.162 PTEN hamartoma tumor syndromes
Nature Reviews Molecular Cell Biology Ma 10 307 2009 10.1038/nrm2672 Molecular mechanisms of mTOR-mediated translational control
American Journal of Medical Genetics Goffin 105 521 2001 10.1002/ajmg.1477 PTEN mutation in a family with Cowden syndrome and autism
Neuron Kwon 50 377 2006 10.1016/j.neuron.2006.03.023 Pten regulates neuronal arborization and social interaction in mice
Genetics in Medicine Varga 11 111 2009 10.1097/GIM.0b013e31818fd762 The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly
Journal of Medical Genetics Neves-Pereira 46 759 2009 10.1136/jmg.2009.066852 Deregulation of EIF4E: a novel mechanism for autism
Nature Gkogkas 493 371 2013 10.1038/nature11628 Autism-related deficits via dysregulated eIF4E-dependent translational control
Current Opinion in Neurobiology Krey 17 112 2007 10.1016/j.conb.2007.01.010 Molecular mechanisms of autism: a possible role for Ca2+ signaling
Cell Splawski 119 19 2004 10.1016/j.cell.2004.09.011 Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism
Proceedings of the National Academy of Sciences of the United States of America Hemara-Wahanui 102 7553 2005 10.1073/pnas.0501907102 A CACNA1F mutation identified in an X-linked retinal disorder shifts the voltage dependence of the Cav1.4 channel activation
Clinical and Experimental Ophthalmology Hope 33 129 2005 10.1111/j.1442-9071.2005.00987.x Clinical manifestations of a unique X-linked retinal disorder in a large New Zealand family with a novel mutation in CACNA1F, the gene responsible for CSNB2
American Journal of Psychiatry Laumonnier 163 1622 2006 10.1176/ajp.2006.163.9.1622 Association of a functional deficit of the BKCa channel, a synaptic regulator of neuronal excitability, with autism and mental retardation
Molecular Psychiatry Weiss 8 186 2003 10.1038/sj.mp.4001241 Sodium channels SCN1A, SCN2A and SCN3A in familial autism
JAMA Giulivi 304 2389 2010 10.1001/jama.2010.1706 Mitochondrial dysfunction in autism
Molecular Psychiatry Rossignol 17 290 2012 10.1038/mp.2010.136 Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
Biochimica et Biophysica Acta Palmieri 1797 1130 2010 10.1016/j.bbabio.2010.04.018 Mitochondrial dysfunction in autism spectrum disorders: cause or effect?
Annals of Human Genetics Hadjixenofontos 77 9 2013 10.1111/j.1469-1809.2012.00736.x Evaluating mitochondrial DNA variation in autism spectrum disorders
PLoS ONE Weissman 3 e3815 2008 10.1371/journal.pone.0003815 Mitochondrial disease in autism spectrum disorder patients: a cohort analysis
Journal of Child Neurology Shoffner 25 429 2008 10.1177/0883073809342128 Fever plus mitochondrial disease could be risk factors for autistic regression
Journal of Child Neurology Nissenkorn 15 44 2000 10.1177/088307380001500110 Neurologic presentations of mitochondrial disorders
Annals of the New York Academy of Sciences Smith 1151 102 2009 10.1111/j.1749-6632.2008.03571.x Nuclear and mitochondrial genome defects in autisms
Falconer 1981 Introduction to quantitative genetics
Archives of General Psychiatry Robinson 68 1113 2011 10.1001/archgenpsychiatry.2011.119 Evidence that autistic traits show the same etiology in the general population and at the quantitative extremes (5%, 2.5%, and 1%)
Molecular Autism Klei 3 9 2012 10.1186/2040-2392-3-9 Common genetic variants, acting additively, are a major source of risk for autism
Human Molecular Genetics Anney 21 4781 2012 10.1093/hmg/dds301 Individual common variants exert weak effects on the risk for autism spectrum disorders
Trends in Neurosciences Persico 29 349 2006 10.1016/j.tins.2006.05.010 Searching for ways out of the autism maze: genetic, epigenetic and environmental clues
Molecular Psychiatry Freitag 12 2 2007 10.1038/sj.mp.4001896 The genetics of autistic disorders and its clinical relevance: a review of the literature
Nature Reviews Genetics Abrahams 9 341 2008 10.1038/nrg2346 Advances in autism genetics: on the threshold of a new neurobiology
Expert Review of Molecular Diagnostics Weiss 9 795 2009 10.1586/erm.09.59 Autism genetics: emerging data from genome-wide copy-number and single nucleotide polymorphism scans
Trends in Genetics Merikangas 25 536 2009 10.1016/j.tig.2009.10.006 Copy-number variants in neurodevelopmental disorders: promises and challenges
Annual Review of Medicine Stankiewicz 61 437 2010 10.1146/annurev-med-100708-204735 Structural variation in the human genome and its role in disease
Nature Weiss 461 802 2009 10.1038/nature08490 A genome-wide linkage and association scan reveals novel loci for autism
Nature Wang 459 528 2009 10.1038/nature07999 Common genetic variants on 5p14.1 associate with autism spectrum disorders
Annals of Human Genetics Ma 73 263 2009 10.1111/j.1469-1809.2009.00523.x A genome-wide association study of autism reveals a common novel risk locus at 5p14.1
Science Translational Medicine Kerin 4 128ra40 2012 10.1126/scitranslmed.3003479 A noncoding RNA antisense to moesin at 5p14.1 in autism
Behavior Genetics Ronald 40 31 2010 10.1007/s10519-009-9308-6 A genome-wide association study of social and non-social autistic-like traits in the general population using pooled DNA, 500K SNP microarrays and both community and diagnosed autism replication samples
Human Molecular Genetics Anney 19 4072 2010 10.1093/hmg/ddq307 A genome-wide scan for common alleles affecting risk for autism
Molecular Psychiatry Lu 17 215 2012 10.1038/mp.2010.127 Allowing for sex differences increases power in a GWAS of multiplex Autism families
Molecular Psychiatry Maestrini 15 954 2009 10.1038/mp.2009.34 High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L-DOCK4 gene region in autism susceptibility
Rutter 2003 ADI-R, autism diagnostic interview-revised
PLoS ONE Hu 6 e19067 2011 10.1371/journal.pone.0019067 Novel autism subtype-dependent genetic variants are revealed by quantitative trait and subphenotype association analyses of published GWAS data
Child Development Connolly 84 17 2013 10.1111/j.1467-8624.2012.01838.x A genome-wide association study of autism incorporating autism diagnostic interview-revised, autism diagnostic observation schedule, and social responsiveness scale
Human Genetics Casey 131 565 2012 10.1007/s00439-011-1094-6 A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder
Journal of Human Genetics Rabbani 57 621 2012 10.1038/jhg.2012.91 Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders
Nature Sanders 485 237 2012 10.1038/nature10945 De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Nature Neale 485 242 2012 10.1038/nature11011 Patterns and rates of exonic de novo mutations in autism spectrum disorders
Nature O’Roak 485 246 2012 10.1038/nature10989 Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations
Neuron Iossifov 74 285 2012 10.1016/j.neuron.2012.04.009 De novo gene disruptions in children on the autistic spectrum
Molecular Psychiatry Hultman 16 1203 2011 10.1038/mp.2010.121 Advancing paternal age and risk of autism: new evidence from a population-based study and a meta-analysis of epidemiological studies
Molecular Psychiatry Ben-David 2012 Combined analysis of exome sequencing points toward a major role for transcription regulation during brain development in autism
PLoS Genetics Chahrour 8 e1002635 2012 10.1371/journal.pgen.1002635 Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism
Human Mutation Bi 33 1635 2012 10.1002/humu.22174 Mutations of ANK3 identified by exome sequencing are associated with Autism susceptibility
Nature Genetics Ripke 43 969 2011 10.1038/ng.940 Genome-wide association study identifies five new schizophrenia loci
Science Novarino 338 394 2012 10.1126/science.1224631 Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy
Human Mutation Puffenberger 33 1639 2012 10.1002/humu.22237 A homozygous missense mutation in HERC2 associated with global developmental delay and autism spectrum disorder
Translational Psychiatry Nava 2 e179 2012 10.1038/tp.2012.102 Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including TMLHE
Science O’Roak 338 1619 2012 10.1126/science.1227764 Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders
Cell Michaelson 151 1431 2012 10.1016/j.cell.2012.11.019 Whole-genome sequencing in autism identifies hot spots for de novo germline mutation
Neuron Stein 77 209 2013 10.1016/j.neuron.2013.01.010 Rare inherited variation in autism: beginning to see the forest and a few trees
Neuron Lim 77 235 2013 10.1016/j.neuron.2012.12.029 Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders
Neuron Yu 77 259 2013 10.1016/j.neuron.2012.11.002 Using whole-exome sequencing to identify inherited causes of autism
Methods in Molecular Biology Marshall 838 115 2012 10.1007/978-1-61779-507-7_5 Detection and characterization of copy number variation in autism spectrum disorder
Psychopharmacology Vorstman 2013 Using genetic findings in autism in the development of new pharmaceutical compounds
Psychopharmacology Ruggeri 2013 Biomarkers in Autism Spectrum Disorder
Molecular Autism Carayol 2 17 2011 10.1186/2040-2392-2-17 Autism risk assessment in siblings of affected children using sex-specific genetic scores
Pediatrics Dawson 125 e17 2010 10.1542/peds.2009-0958 Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model
Nature Reviews Drug Discovery Murphy 11 815 2012 10.1038/nrd3881 EU-AIMS: a boost to autism research
Journal of Autism and Developmental Disorders Cohen 35 103 2005 10.1007/s10803-004-1038-2 Specific genetic disorders and autism: clinical contribution towards their identification
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Zafeiriou 2013 10.1002/ajmg.b.32152 autism spectrum disorders: the quest for genetic syndromes
Journal of Developmental and Behavioral Pediatrics Rogers 22 409 2001 10.1097/00004703-200112000-00008 The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders
Autism Kielinen 8 49 2004 10.1177/1362361304040638 Associated medical disorders and disabilities in children with autistic disorder: a population-based study
Journal of Autism and Developmental Disorders Clifford 37 738 2007 10.1007/s10803-006-0205-z Autism spectrum phenotype in males and females with fragile X full mutation and premutation
Journal of the American Academy of Child and Adolescent Psychiatry Fombonne 36 1561 1997 Autism and associated medical disorders in a French epidemiological survey
Journal of Autism and Developmental Disorders Fombonne 33 365 2003 10.1023/A:1025054610557 Epidemiological surveys of autism and other pervasive developmental disorders: an update
Journal of Child Neurology Wong 21 199 2006 10.2310/7010.2006.00046 Study of the relationship between tuberous sclerosis complex and autistic disorder
Journal of Autism and Developmental Disorders Williams 28 567 1998 10.1023/A:1026012414193 Brief report: the association of neurofibromatosis type 1 and autism
Journal of Autism and Developmental Disorders Baieli 33 201 2003 10.1023/A:1022999712639 Autism and phenylketonuria
American Journal of Medical Genetics Fon 60 554 1995 10.1002/ajmg.1320600614 Adenylosuccinate lyase (ADSL) and infantile autism: absence of previously reported point mutation
Mental Retardation and Developmental Disabilities Research Reviews Tierney 6 131 2000 10.1002/1098-2779(2000)6:2<131::AID-MRDD7>3.0.CO;2-R Behavioral phenotype of RSH/Smith-Lemli-Opitz syndrome
European Child and Adolescent Psychiatry Howlin 14 57 2005 10.1007/s00787-005-0416-4 Behavioural characteristics and autistic features in individuals with Cohen syndrome
Journal of Child Psychology and Psychiatry and Allied Disciplines Moss 53 883 2012 10.1111/j.1469-7610.2012.02540.x Characteristics of autism spectrum disorder in Cornelia de Lange syndrome
Orphanet Journal of Rare Diseases Baujat 2 36 2007 10.1186/1750-1172-2-36 Sotos syndrome
American Journal of Medical Genetics Naqvi 94 149 2000 10.1002/1096-8628(20000911)94:2<149::AID-AJMG7>3.0.CO;2-# Cole-Hughes macrocephaly syndrome and associated autistic manifestations
American Journal of Medical Genetics Part A Lerma-Carrillo 140A 2807 2006 10.1002/ajmg.a.31503 Psychopathology in the Lujan-Fryns syndrome: report of two patients and review
American Journal of Psychiatry Ritvo 146 194 1989 10.1176/ajp.146.2.194 The UCLA-University of Utah epidemiologic survey of autism: prevalence
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Chaste 144B 228 2007 10.1002/ajmg.b.30440 Mutation screening of the ARX gene in patients with autism
Current Opinion in Pediatrics Sherr 15 567 2003 10.1097/00008480-200312000-00004 The ARX story (epilepsy, mental retardation, autism, and cerebral malformations): one gene leads to many phenotypes
Journal of Medical Genetics Aldred 41 433 2004 10.1136/jmg.2003.017202 Molecular analysis of 20 patients with 2q37.3 monosomy: definition of minimum deletion intervals for key phenotypes
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Leyfer 141B 615 2006 10.1002/ajmg.b.30344 Prevalence of psychiatric disorders in 4 to 16-year-olds with Williams syndrome
PLoS ONE Tordjman 7 e30778 2012 10.1371/journal.pone.0030778 Autistic disorder in patients with Williams-Beuren syndrome: a reconsideration of the Williams-Beuren syndrome phenotype
European Journal of Medical Genetics Van der Aa 52 94 2009 10.1016/j.ejmg.2009.02.006 Fourteen new cases contribute to the characterization of the 7q11.23 microduplication syndrome
Autism Trillingsgaard 8 163 2004 10.1177/1362361304042720 Autism in Angelman syndrome: an exploration of comorbidity
Journal of Medical Genetics Sahoo 43 512 2006 10.1136/jmg.2005.036913 Microarray based comparative genomic hybridization testing in deletion bearing patients with Angelman syndrome: genotype-phenotype correlations
Neurogenetics Bonati 8 169 2007 10.1007/s10048-007-0086-0 Evaluation of autism traits in Angelman syndrome: a resource to unfold autism genes
American Journal of Medical Genetics Part A Descheemaeker 140A 1136 2006 10.1002/ajmg.a.31235 Pervasive developmental disorders in Prader-Willi syndrome: the Leuven experience in 59 subjects and controls
Neurobiology of Disease Hogart 38 181 2010 10.1016/j.nbd.2008.08.011 The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13
American Journal of Medical Genetics Rineer 81 428 1998 10.1002/(SICI)1096-8628(19980907)81:5<428::AID-AJMG12>3.0.CO;2-E Autistic symptoms among children and young adults with isodicentric chromosome 15
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics Battaglia 154C 448 2010 10.1002/ajmg.c.30281 The behavioral phenotype of the idic(15) syndrome
Brain and Development Pascual-Castroviejo 20 36 1998 10.1016/S0387-7604(97)00097-1 Hypomelanosis of Ito. A study of 76 infantile cases
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics Laje 154C 456 2010 10.1002/ajmg.c.30275 Autism spectrum features in Smith-Magenis syndrome
American Journal of Human Genetics Potocki 80 633 2007 10.1086/512864 Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype
Journal of Autism and Developmental Disorders Lowenthal 37 1394 2007 10.1007/s10803-007-0374-4 Prevalence of pervasive developmental disorder in Down's syndrome
Autism Moss 2012 Prevalence of autism spectrum disorder symptomatology and related behavioural characteristics in individuals with Down syndrome
Journal of Autism and Developmental Disorders Fine 35 461 2005 10.1007/s10803-005-5036-9 Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome
Genetics in Medicine Niklasson 3 79 2001 10.1097/00125817-200101000-00017 Neuropsychiatric disorders in the 22q11 deletion syndrome
Neuropediatrics Lo-Castro 40 137 2009 10.1055/s-0029-1237724 Association of syndromic mental retardation and autism with 22q11.2 duplication
American Journal of Human Genetics Laumonnier 74 552 2004 10.1086/382137 X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family
European Journal of Human Genetics Lawson-Yuen 16 614 2008 10.1038/sj.ejhg.5202006 Familial deletion within NLGN4 associated with autism and Tourette syndrome
Biological Psychiatry Daoud 66 906 2009 10.1016/j.biopsych.2009.05.008 Autism and nonsyndromic mental retardation associated with a de novo mutation in the NLGN4X gene promoter causing an increased expression level
Genetic Testing and Molecular Biomarkers Pampanos 13 611 2009 10.1089/gtmb.2009.0005 A substitution involving the NLGN4 gene associated with autistic behavior in the Greek population
Genetic Counseling Avdjieva-Tzavella 23 505 2012 Analysis of the genes encoding neuroligins NLGN3 and NLGN4 in Bulgarian patients with autism
Journal of Neuroscience Zhang 29 10843 2009 10.1523/JNEUROSCI.1248-09.2009 A neuroligin-4 missense mutation associated with autism impairs neuroligin-4 folding and endoplasmic reticulum export
Journal of Medical Genetics Talebizadeh 43 e21 2006 10.1136/jmg.2005.036897 Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism
Psychiatric Genetics Yan 18 204 2008 10.1097/YPG.0b013e3282fb7fe6 Analysis of the neuroligin 4Y gene in patients with autism
PLoS ONE Kelleher 7 e35003 2012 10.1371/journal.pone.0035003 High-throughput sequencing of mGluR signaling pathway genes reveals enrichment of rare variants in autism
Psychiatric Genetics Waga 21 208 2011 10.1097/YPG.0b013e328341e069 Novel variants of the SHANK3 gene in Japanese autistic patients with severe delayed speech development
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Gauthier 150B 421 2009 10.1002/ajmg.b.30822 Novel de novo SHANK3 mutation in autistic patients
Neuroscience Letters Feng 409 10 2006 10.1016/j.neulet.2006.08.017 High frequency of neurexin 1beta signal peptide structural variants in patients with autism
American Journal of Human Genetics Kim 82 199 2008 10.1016/j.ajhg.2007.09.011 Disruption of neurexin 1 associated with autism spectrum disorder
Neuroscience Letters Yan 438 368 2008 10.1016/j.neulet.2008.04.074 Neurexin 1alpha structural variants associated with autism
American Journal of Human Genetics Zweier 85 655 2009 10.1016/j.ajhg.2009.10.004 CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Duong 159B 354 2012 10.1002/ajmg.b.32036 Mutations in NRXN1 in a family multiply affected with brain disorders: NRXN1 mutations and brain disorders
Journal of Psychiatric Research Liu 46 630 2012 10.1016/j.jpsychires.2011.10.015 Mutation analysis of the NRXN1 gene in a Chinese autism cohort
Neurobiology of Disease Camacho-Garcia 47 135 2012 10.1016/j.nbd.2012.03.031 Mutations affecting synaptic levels of neurexin-1β in autism and mental retardation
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Béna 162 388 2013 10.1002/ajmg.b.32148 Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature
American Journal of Medical Genetics Part A Dabell 161 717 2013 10.1002/ajmg.a.35780 Investigation of NRXN1 deletions: clinical and molecular characterization
European Journal of Human Genetics Schaaf 20 1240 2012 10.1038/ejhg.2012.95 Phenotypic spectrum and genotype-phenotype correlations of NRXN1 exon deletions
European Journal of Human Genetics Vourc’h 9 556 2001 10.1038/sj.ejhg.5200660 No mutations in the coding region of the Rett syndrome gene MECP2 in 59 autistic patients
Human Genetics Beyer 111 305 2002 10.1007/s00439-002-0786-3 Mutation analysis of the coding sequence of the MECP2 gene in infantile autism
Pediatric Neurology Carney 28 205 2003 10.1016/S0887-8994(02)00624-0 Identification of MeCP2 mutations in a series of females with autistic disorder
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Zappella 119B 102 2003 10.1002/ajmg.b.10070 Study of MECP2 gene in Rett syndrome variants and autistic girls
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Shibayama 128B 50 2004 10.1002/ajmg.b.30016 MECP2 structural and 3′-UTR variants in schizophrenia, autism and other psychiatric diseases: a possible association with autism
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Lobo-Menendez 117B 97 2004 10.1002/ajmg.b.10016 Absence of MeCP2 mutations in patients from the South Carolina autism project
Brain and Development Li 27 321 2005 10.1016/j.braindev.2004.08.003 Mutation analysis of methyl-CpG binding protein family genes in autistic patients
Psychiatric Genetics Xi 17 113 2007 10.1097/YPG.0b013e3280114a5c MeCP2 gene mutation analysis in autistic boys with developmental regression
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Harvey 144B 355 2007 10.1002/ajmg.b.30425 Sequence variants within exon 1 of MECP2 occur in females with mental retardation
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Coutinho 144B 475 2007 10.1002/ajmg.b.30490 MECP2 coding sequence and 3’UTR variation in 172 unrelated autistic patients
Autism Research Cukier 5 385 2012 10.1002/aur.1251 The expanding role of MBD genes in autism: identification of a MECP2 duplication and novel alterations in MBD5, MBD6, and SETDB1
BMC Medical Genetics Xu 13 75 2012 10.1186/1471-2350-13-75 A case report of Chinese brothers with inherited MECP2-containing duplication: autism and intellectual disability, but not seizures or respiratory infections
Brain and Development Campos 33 807 2011 10.1016/j.braindev.2011.04.015 A MECP2 missense mutation within the MBD domain in a Brazilian male with autistic disorder
Molecular Psychiatry Piton 16 867 2011 10.1038/mp.2010.54 Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia
Pediatric Research Psoni 67 551 2010 10.1203/PDR.0b013e3181d4ecf7 Phenotypic and genotypic variability in four males with MECP2 gene sequence aberrations including a novel deletion
Journal of Medical Genetics Butler 42 318 2005 10.1136/jmg.2004.024646 Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations
American Journal of Medical Genetics Part A Boccone 140A 1965 2006 10.1002/ajmg.a.31396 Bannayan-Riley-Ruvalcaba syndrome with reactive nodular lymphoid hyperplasia and autism and a PTEN mutation
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics Buxbaum 144B 484 2007 10.1002/ajmg.b.30493 Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly
Clinical Genetics Orrico 75 195 2009 10.1111/j.1399-0004.2008.01074.x mutations in neurodevelopmental disorders and macrocephaly
American Journal of Medical Genetics Part A Herman 143 589 2007 10.1002/ajmg.a.31619 Increasing knowledge of PTEN germline mutations: Two additional patients with autism and macrocephaly
European Journal of Human Genetics Hobert 2013 Biochemical screening and PTEN mutation analysis in individuals with autism spectrum disorders and macrocephaly
Autism Research Klein 6 51 2013 10.1002/aur.1266 Macrocephaly as a clinical indicator of genetic subtypes in autism
Journal of Child Neurology Conti 27 392 2012 10.1177/0883073811420296 Phosphatase and tensin homolog (PTEN) gene mutations and autism: literature review and a case report of a patient with Cowden syndrome, autistic disorder, and epilepsy
Journal of Developmental and Behavioral Pediatrics Stein 31 632 2010 10.1097/DBP.0b013e3181ef422a Autistic spectrum disorder in a 9-year-old girl with macrocephaly
Autism Research McBride 3 137 2010 10.1002/aur.132 Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly
Journal of Biological Chemistry Splawski 281 22085 2006 10.1074/jbc.M603316200 CACNA1H mutations in autism spectrum disorders
Journal of Child Neurology Graf 15 357 2000 10.1177/088307380001500601 Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation
Journal of Child Neurology Fillano 17 435 2002 10.1177/088307380201700607 Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome
Journal of Pediatrics Pons 144 81 2004 10.1016/j.jpeds.2003.10.023 abnormalities and autistic spectrum disorders
Cell Journal Piryaei 14 98 2012 Investigation of the mitochondrial ATPase 6/8 and tRNA(Lys) genes mutations in autism
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.